Upcoming NurOwn Adcomm Highlights Regulatory Role for Patient Advocates

Patient advocacy organizations have long been influential in the drug development landscape. Most recently, they have played a larger role in the regulatory space, and advisory committee meetings are a prime opportunity for patients to have a say in the drug approval process. But recent approvals—particularly in the neurogenerative and neuromuscular spaces—have ignited a debate among experts about the ethics of this influence and a call for greater transparency.